Skip to main content
. 2015 Jul 20;6(29):28011–28025. doi: 10.18632/oncotarget.4377

Table 1. Mouse body weight (g) (mean ± SD).

Group Average body weight 25 weeks (g) Average body weight 30 weeks (g) Survival (%)
Preventive study
Saline 31.22 ± 1.39 100
DEN + control 26.75 ± 1.96*** 75
DEN + low dose TUDCA 27.39 ± 1.45# 83
DEN + high dose TUDCA 24.64 ± 2.17# 67
Therapeutic study
DEN ⇒ control 25.96 ± 3.65 22.92 ± 3.19 67
DEN ⇒ low dose TUDCA 23.86 ± 2.70 22.13 ± 2.57¥ 75
DEN ⇒ high dose TUDCA 24.53 ± 2.13 23.43 ± 2.61¥ 67
***

p < 0.001: 25 weeks DEN vs. saline.

#

not significant compared to DEN + control.

¥

not significant compared to DEN ⇒ control.

DEN, diethylnitrosamine.